KALARIS THERAPEUTICS, INC. (KLRS) Shareholders’ equity

KALARIS THERAPEUTICS, INC. (KLRS) shareholders’ equity at each fiscal year-end, per SEC filings.

-$51.5MFY2020

Fiscal year	Value	YoY
FY2020	-$51.5M	—

Source: SEC XBRL filings · For reference only · Not investment advice

More KLRS financial trends

KLRS Revenue KLRS Net income KLRS Net margin KLRS Gross profit KLRS Gross margin KLRS Operating income KLRS Operating margin KLRS Operating cash flow KLRS Free cash flow KLRS Capital expenditures KLRS Return on equity KLRS Stock buybacks KLRS Dividends paid KLRS Total assets KLRS Total liabilities KLRS overview →